
Berenberg upgraded Orsted A/S to Buy, citing a significantly strengthened balance sheet from its recent DKK60 billion rights issue, which enhances its capital expenditure funding capacity through 2027 even amid US offshore project uncertainties like the Revolution Wind halt. Despite the stock's near 50% decline and ongoing US project challenges, Berenberg believes most downside risk is priced in, suggesting a floor valuation of DKK172. This positive outlook is echoed by UBS and Morgan Stanley, with the latter upgrading Orsted to Overweight, anticipating a favorable shift in the renewables cycle for the Danish utility.
Orsted A/S (ORSTED:DC) presents a complex investment case, marked by a contrast between severe operational headwinds and a newly fortified financial position leading to positive analyst revisions. Despite a nearly 50% stock price decline over the past year and the stock trading in oversold territory, Berenberg has upgraded the company to Buy. This is predicated on a recent DKK60 billion rights issue which sufficiently strengthens the balance sheet to fund capital expenditures through 2027, even if its troubled US offshore projects are cancelled. These challenges are significant, including a halt order of unknown duration for its 704MW Revolution Wind project and an inability to secure financing or partners for its Sunrise Wind project. However, Berenberg calculates a floor valuation of DKK172 per share, suggesting much of this downside risk is already reflected in the current price. This cautiously optimistic sentiment is echoed by other major firms; UBS maintains a Buy rating with a DKK360 price target, and Morgan Stanley recently upgraded the stock to Overweight, also with a DKK360 target, citing an expected favorable shift in the broader renewables cycle.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request a DemoOverall Sentiment
mixed
Sentiment Score
0.10
Ticker Sentiment